Working Groups

The DZIF working group “Translation of evolutionary principles into antimicrobial treatment strategies,” led by Hakim Boudrioua, will develop therapeutic strategies and diagnostic tools that integrate key evolutionary principles to combat antimicrobial resistance. The aim is to optimize single and ...

The working group of Prof. Jörg Janne Vehreschild in Cologne cooperates with the Robert Koch Institute. To pave the way for the upcoming challenges in HIV research, the Translational Platform was founded in 2015. It supports clinical and epidemiological cohort studies in HIV. The platform provides ...

Marc Hübner aims to identify new drug candidates against parasitic threadworms, so-called filariae, and developing them further for human use. To this end, new in vitro and in vivo models are being developed and identified candidates are being tested in clinical trials in humans. With oxfendazole ...

In addition to analyzing the replication mechanisms of the hepatitis B (HBV) and D (HDV) viruses, the work of Prof. Stephan Urban and his team focuses on the development of new active substances and drugs against these pathogens. With Bulevirtide (formerly Myrcludex B), which blocks the binding and ...

Medical data and biological samples obtained from transplant patients are collected and managed across Germany with the help of the DZIF Transplant Cohort. The data and samples form the basis of scientific studies which investigate the connections between numerous factors influencing an organ’s ...

The working group is responsible for projects aimed at the detection, occurrence and description of emerging viruses. To accomplish this task, the scientists are collecting samples of potential virus carriers, such as game, farm and domestic animals, thereby building up a comprehensive database ...